home / stock / acer / acer news

ACER News and Press, Acer Therapeutics Inc. From 02/22/22

Stock Information
Company Name: Acer Therapeutics Inc.
Stock Symbol: ACER
Market: NASDAQ
Website: acertx.com
Menu
ACER ACER Quote ACER Short ACER News ACER Articles ACER Message Board
Get ACER Alerts

News, Short Squeeze, Breakout and More Instantly...
ACER - Acer Therapeutics Announces Appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer

NEWTON, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced th...
ACER - Acer Therapeutics to Participate in 2022 BIO CEO & Investor Conference

NEWTON, Mass., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced t...

ACER - Acer Therapeutics secures new U.S. patent for ACER-001 for urea cycle disorders

Relief Therapeutics (OTCQB:RLFTF) announced that its collaboration partner, Acer Therapeutics (NASDAQ:ACER), has been issued a new patent from the USPTO for certain claims related to ACER-001 (sodium phenylbutyrate). Specifically, patent 11,202,767 covers methods of use claims related to ACER...

ACER - Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences

NEWTON, Mass. and GENEVA, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced the acceptance of four ACER-001 abstracts...
ACER - Acer Therapeutics to Participate in January 2022 Virtual Investor Conferences

NEWTON, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced th...

ACER - Acer Therapeutics wins FDA nod for hot flashes trial

Acer Therapeutics (NASDAQ:ACER) has gained ~3.3% in the pre-market after announcing the FDA clearance of its Investigational New Drug (IND) application for ACER-801 (osanetant) as a treatment for induced Vasomotor Symptoms ((iVMS)). ACER-801 is a non-hormonal drug designed as a selective non-...

ACER - Acer Therapeutics Announces ACER-801 IND Clearance for the Treatment of Induced Vasomotor Symptoms

Phase 2a trial initiation expected in Q1 2022 Trial designed to generate proof of concept data for ACER-801 and identify optimal dose for subsequent efficacy trials in patients with iVMS NEWTON, Mass., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), ...
ACER - Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

NEWTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported fin...

ACER - Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation

NEWTON, Mass. and GENEVA, Switzerland, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Patent and Tra...

ACER - JYNT, BCYC and FAMI among mid-day movers

Gainers: Camber Energy (NYSE:CEI) +97%. Merus (NASDAQ:MRUS) +32%. New Fortress Energy (NASDAQ:NFE) +25%. Paltalk (NASDAQ:PALT) +25%. Grom Social Enterprises (NASDAQ:GROM) +20%. DatChat (NASDAQ:DATS) +20%. Jupiter Wellness (NASDAQ:JUPW) +18%. NextPlay Technologies (NASDAQ:NXTP) +19%. Independe...
Previous 10 Next 10